FOCUSED
ON YOUR HEALTH



ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

ATC code M: Musculo-skeletal system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.

Muscolo - Skeletal System

Tablets – 100 mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (urate nephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Tablets - 300mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (uratenephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Granules for oral suspension - 100 mg

Cox-in contains the active substance nimesulide. It belongs to a group of medicines called non-steroidal antiinflammatory drugs (NSAIDs) and has analgesic properties.

Cox-in is used for the treatment of acute pain and menstrual pain.

Nimesulide should only be prescribed as second-line treatment.

Solution for injection - 160 mg / 2 ml

Dolomed contains the active substance ketoprofen lysine.

Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory drug (NSAID).

Dolomed is indicated in:

  • the treatment of acute exacerbations of musculoskeletal, joint, articular, peri-articular and soft tissue disorders;

the management of pain after orthopaedic surgery.

Suppositories - 100 mg

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

 

Solution for injection - 75 mg / 3 ml

 

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

Gel - 1%

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

 

Granules for oral solution - 40 mg

 

Granules for oral solution

 

Suppositories – 75 mg

Oral suspension - 100 mg / 5 ml

 

Film coated tablets - 600 mg

 

Film coated tablets - 400 mg

 

Film coated tablets - 400 mg

 

Suppositories – 150 mg

Results 1 - 15 of 23

Recently viewed

Film coated tablets - 180 mg

 

Tablets - 0.5 mg

Tablets - 25 mg

Rectal solution - 5 mg/2.5 ml

Solution - 10 %